Cara Therapeutics Inc (NASDAQ:CARA)
| 17.31 Delayed Data As of Jan 17 |  +0.415 / +2.46%Today’s Change | 14.10 Today|||52-Week Range 27.55 | +7.42% Year-to-Date |
Latest CARA News | Press Releases
| Why Your 2020 Resolution Should Be to Buy More Small-Cap Stocks Jan 05 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.89 |
| Today’s open | 17.05 |
| Day’s range | 16.93 - 17.36 |
| Volume | 685,001 |
| Average volume (3 months) | 713,932 |
| Market cap | $733.8M |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | -10.87% |
| Earnings growth (this year) | -23.89% |
| Earnings growth (next 5 years) | -66.83% |
| Revenue growth (last year) | +1,378.49% |
| P/E ratio | NM |
| Price/Sales | 34.64 |
| Price/Book | 4.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRAAtara Biotherapeutic... | -0.96 | -6.00% |
| ZIOPZIOPHARM Oncology In... | -0.34 | -6.83% |
| STOKStoke Therapeutics I... | -0.14 | -0.59% |
| FIXXHomology Medicines I... | -0.27 | -1.53% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | March 26, 2020 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $13.5M |
| Annual profit (last year) | -$74.0M |
| Net profit margin | -549.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stamford, Connecticut |
Forecasts
